A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID
Stefanie M. Bader(The University of Melbourne), David Komander(Walter and Eliza Hall Institute of Medical Research), Rohan Volpe(The University of Melbourne), T. Blackmore(The University of Melbourne), Merle Dayton(Walter and Eliza Hall Institute of Medical Research), Reet Bhandari(The University of Melbourne), Jan Schaefer(The University of Melbourne), Nathan W. Kuchel(The University of Melbourne), Angus T. Stock(The University of Melbourne), Dale J. Calleja(The University of Melbourne), Marcel Doerflinger(The University of Melbourne), Shane M. Devine(The University of Melbourne), Kasiram Katneni(Monash University), Cody C. Allison(The University of Melbourne), Theresa Klemm(The University of Melbourne), Bernadine G.C. Lu(The University of Melbourne), Jeffrey P. Mitchell(University of California, Davis), Melissa Call(The University of Melbourne), Kael L. Schoffer(The University of Melbourne), Tracy L. Putoczki(The University of Melbourne), Maria C. Tanzer(The University of Melbourne), Anthony J. Hannan(The University of Melbourne), Smitha R. Georgy(The University of Melbourne), Marc Pellegrini(The University of Melbourne), Richard W. Birkinshaw(The University of Melbourne), Peter E. Czabotar(The University of Melbourne), Gregor Ebert(Helmholtz Zentrum München), Ueli Nachbur(The University of Melbourne), Ana Maluenda(Walter and Eliza Hall Institute of Medical Research), Susan A. Charman(Monash University), Bernhard C. Lechtenberg(Walter and Eliza Hall Institute of Medical Research), Kym N. Lowes(The University of Melbourne), James P. Cooney(The University of Melbourne), Liana Mackiewicz(Walter and Eliza Hall Institute of Medical Research), Elizabeth A. Kleeman(The University of Melbourne), Guillaume Lessène(The University of Melbourne), Katie Loi(The University of Melbourne), Gong� Chen(Central South University), Xinyu Wu(Wenzhou Medical University), Kathryn C. Davidson(Australian Regenerative Medicine Institute), Amanda E. Au(The University of Melbourne), L.R. Scherer(University of Tennessee Health Science Center), Yelena Khakham(Walter and Eliza Hall Institute of Medical Research)
Cited by 35
Related Papers
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
|Cell Death and Differentiation|2018|6.6k
IL-11 is a crucial determinant of cardiovascular fibrosis
|Nature|2017|663
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
|Science Translational Medicine|2015|541
Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
|The EMBO Journal|2020|499